Linde | LIN - Cash And Equivalent


Linde reported $3.96B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Air Products & Chemicals USD 980.5M 29.5M Jun/2026
Acerinox EUR 845M 124.89M Mar/2026
Air Liquide EUR 3.96B 2.05B Dec/2025
Akzo Nobel EUR 2.76B 1.14B Mar/2026
Arkema EUR 1.73B 458.1M Mar/2026
BASF EUR 7.8B 4.71B Jun/2026
Bayer EUR 5.73B 943M Mar/2026
Corteva USD 2.37B 401M Jun/2026
Covestro EUR 648M 44M Dec/2025
Dow USD 4.11B 294M Mar/2026
Dupont De Nemours USD 1.74B 1.03B Jun/2026
Henkel EUR 2.71B 163M Dec/2025
Huntsman USD 369M 60M Mar/2026
Johnson Matthey GBP 542M 49M Jun/2024
Linde USD 3.96B 1.1B Mar/2026
LyondellBasell Industries USD 2.63B 5M Jun/2026
Merck EUR 2.33B 77M Dec/2025
PPG Industries USD 1.52B 53M Jun/2026
Sherwin-Williams USD 293.5M 76.6M Jun/2026
Sika AG CHF 1.87B 1.18B Dec/2022
Solvay EUR 367M 119M Jun/2026
Umicore EUR 1.56B 450.17M Dec/2025
Westlake Chemical USD 1.64B 628M Jun/2026